ALGN
Align Technology, Inc.162.89
+0.16+0.1%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
FY Q3 '25
Key Stats
Market Cap
11.81BP/E (TTM)
31.57Basic EPS (TTM)
5.16Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Align Technology posted Q3 revenue of $996M, up 1.8% y/y yet flat q/q amid restructuring drag, with Clear Aligner volume rising 4.9% y/y to offset ASP erosion from mix shifts. Gross margin slipped to 64.2% from 69.7% y/y, hammered by $23M assets-held-for-sale impairment, $15M inventory write-down, and accelerated depreciation on manufacturing disposals—but op income held at $96M. Diluted EPS of $0.78 matched basic on 72.4M shares, down sharply from $1.55 y/y. Cash sits at $1.0B with $370M YTD operating cash flow and $300M revolver untapped; share repurchases consumed $369M YTD. Restructuring targets workforce cuts through Q4. Antitrust suits linger.
8-K
Q3 revenues beat; restructuring hits
Align Technology posted Q3 revenues of $995.7M, up 1.8% year-over-year yet down 1.7% sequentially, beating guidance amid $88.3M restructuring charges that hammered GAAP margins to 9.7% while non-GAAP held at 23.9%. Clear aligner volumes rose 4.9% YoY to 647.8K cases, powered by teen/kids growth internationally; Systems revenues dipped on seasonality. Restructuring sharpens focus. Q4 revenues eyed at $1.025B-$1.045B.
8-K
HR exec termination announced
Align Technology terminated Executive Vice President of Global Human Resources Stuart Hockridge on September 12, 2025, effective May 2026, without cause under his 2016 employment agreement. Severance and benefits will align with proxy disclosures for non-change-of-control terminations. This leadership shift signals a strategic HR pivot. No interim arrangements disclosed.
10-Q
Q2 FY2025 results
Align Technology's Q2 FY2025 results showed net revenues dipping 1.6% y/y to $1.01B, with Clear Aligner down 3.3% y/y to $805M amid softer ASPs from product mix shifts, yet Systems and Services rose 5.6% y/y to $208M on scanner wand strength. Gross margin held at 69.9%, while operating income climbed 10.9% y/y to $163M (derived), lifting diluted EPS 34.4% y/y to $1.72 on 72.6M shares—EPS reconciles cleanly. Cash from operations hit $181M YTD, yielding $134M FCF after $47M capex, with $901M cash and full $300M revolver availability, no debt. The Cubicure acquisition closed Jan 2024 for $85.8M cash, adding $47.6M goodwill and $47M intangibles over 13 years to bolster digital printing. Antitrust suits linger, with a $31.8M Section 1 settlement pending final approval.
8-K
Align launches $200M buyback
Align Technology announced plans to repurchase $200 million of its common stock via open market transactions under its $1.0 billion program approved in April 2025. This move signals management's confidence in the long-term strategy amid macroeconomic uncertainty, funded by cash on hand with completion targeted by January 2026. Repurchases enhance shareholder value. Yet risks like market volatility could alter timing.
IPO
Website
Employees
Sector
Industry
ALC
Alcon Inc.
79.02-0.17
ALHC
Alignment Healthcare, Inc.
20.03-0.08
DROR
Dror Ortho-Design Inc.
0.01+0.00
GEHC
GE HealthCare Technologies Inc.
82.25-2.20
INGN
Inogen, Inc
6.81-0.02
NVST
Envista Holdings Corporation
21.90-0.16
RTGN
RETINALGENIX TECHNOLOGIES INC
3.20+0.00
VVOS
Vivos Therapeutics, Inc.
2.02+0.00
XRAY
DENTSPLY SIRONA Inc.
11.37-0.03
ZIMV
ZimVie Inc.
18.99+0.00